Price target
103.500.000.00%
The 14 analysts offering 1 year price forecasts for ITCI have a max estimate of — and a min estimate of —.
Analyst rating
Based on 16 analysts giving stock ratings to ITCI in the past 3 months.
EPS
Reported
Estimate
Reported
Estimate
Surprise
Revenue
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
ITCI EPS for the last quarter is −0.25 USD despite the estimation of −0.18 USD. In the next quarter EPS is expected to reach −0.07 USD. Track more of Intra-Cellular Therapies Inc. financials and stay on top of what is up with the company.
In the next quarter Intra-Cellular Therapies Inc. revenue is expected to reach 194.05 M USD. Check out Intra-Cellular Therapies Inc. revenue and earnings and make informed decisions.
According to analysts, ITCI price target is 103.50 USD with a max estimate of 135.00 USD and a min estimate of 87.00 USD. Check if this forecast comes true in a year, meanwhile watch Intra-Cellular Therapies Inc. stock price chart and keep track of the current situation with ITCI news and stock market news.
We've gathered opinions of 16 analysts rating ITCI stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.